NCT07216326 Our Voices Matter: Intervention for Depression in Youth
| NCT ID | NCT07216326 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
| Condition | Depressive Symptoms |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-06-06 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-06-06 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Over 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceration) that produce hostile environments that contribute to psychological distress, elevated allostatic load, and an elevated risk for chronic diseases and premature death, concentrated within Black and Latinx populations. While the connection between SRD and health is well documented, few studies provide evidence on strategies to reduce SRD and mitigate consequences on psychological and physiological outcomes. Thus, there is a critical need to rigorously test interventions that improve the mental and physical health of Black and Latinx populations, beginning in adolescence. The study's specific aims are to 1) Determine whether a racial justice activism behavioral intervention prevents and reduces depressive symptoms in Black and Latinx adolescents and young adults and 2) Determine whether a racial justice activism behavioral intervention lowers allostatic load scores in Black and Latinx adolescents and young adults. To accomplish these aims, the team will conduct a stage II group-based, multi-component, and multilevel randomized behavioral clinical trial. The investigators will collect psychological and physiological measures at baseline, then at defined intervals for 2 years post the racial justice activism intervention.
Eligibility Criteria
Inclusion Criteria: 1. 15-20 years old 2. Identify as Black and/ or Latinx 3. Speak English Exclusion Criteria: 1. Younger than 15 years old, or older than 20 years old 2. Unable to attend the in-person sessions 3. Non-fluent English speaker 4. Do not identify as Black or Latinx
Contact & Investigator
Elan C Hope, PhD
PRINCIPAL INVESTIGATOR
Policy Research Associates
Frequently Asked Questions
Who can join the NCT07216326 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 20 Years, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07216326 currently recruiting?
Yes, NCT07216326 is actively recruiting participants. Contact the research team at nheardgarris@luriechildrens.org for enrollment information.
Where is the NCT07216326 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07216326 clinical trial?
NCT07216326 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The principal investigator is Elan C Hope, PhD at Policy Research Associates. The trial plans to enroll 300 participants.